OrbiMed Advisors LLC's Form 4 filing
Adicet Bio, Inc. (ACET) · filed Jun 29, 2023
- Accession no.
- 0000947871-23-000713
- Filed
- Jun 29, 2023, 4:46 PM ET
- Trade date
- Jun 27, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market purchases total $1.83M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | Director, 10% Owner |
| OrbiMed Israel GP Ltd.CIK 0001569590 | Director, 10% Owner |
| OrbiMed Israel BioFund GP Limited PartnershipCIK 0001569821 | Director, 10% Owner |
| OrbiMed Capital GP V LLCCIK 0001615374 | Director, 10% Owner |
| OrbiMed Israel GP II, L.P.CIK 0001682090 | Director, 10% Owner |
| OrbiMed Advisors Israel II LtdCIK 0001682093 | Director, 10% Owner |
| OrbiMed Capital GP VI LLCCIK 0001682115 | Director, 10% Owner |
| Chimovits ErezCIK 0001706399 | Director, 10% Owner |
| OrbiMed Genesis GP LLCCIK 0001808744 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 27, 2023 | Common Stock | PPurchaseAcquired | +125,000 | $2.09F1 | +$261,250 | 1,027,885 | Indirect | Duplicate filing |
| Jun 27, 2023 | Common Stock | PPurchaseAcquired | +250,000 | $2.09F1 | +$522,500 | 646,657 | Indirect | Duplicate filing |
| Jun 27, 2023 | Common Stock | PPurchaseAcquired | +442,000 | $2.09F1 | +$923,780 | 5,685,259 | Indirect | Duplicate filing |
| Jun 27, 2023 | Common Stock | PPurchaseAcquired | +58,000 | $2.09F1 | +$121,220 | 748,054 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average purchase price of the shares of common stock purchased, ranging from a low of $2.08 to a high of $2.12 per share. The Reporting Persons undertake, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 4 transactions in Table I.